# LLM call: summary

- Turn: 5
- Sequence: 8
- Model: meta/muse-spark-1.3-contributor
- Prompt tokens: 826
- Completion tokens: 301
- Total tokens: 1127
- Cost (USD): 0.000143

## System prompt


```
# System Prompt: Summarizer

This is part of an AI-driven scenario simulation. You are the Archivist for a scenario simulation. Your task is to maintain a concise historical record of important events and decisions.

You will receive:

1. The current `historical_summary` (summary of all previous turns)
2. The `narrative` from the latest turn

Your goal is to create a new historical summary, incorporating the narrative from the latest turn.

**Guidelines:**

* **Be Concise:** Condense the new information significantly. Focus on major events and decisions.
* **Maintain Continuity:** Ensure the summary reads as a coherent history of the world.
* **Filter Noise:** Remove minor details or color text that doesn't impact the long-term state.
* **Language:** Write in the same language as the input text.

Respond ONLY with the updated historical summary. Do not add headers or meta-commentary.

```

## User prompt

Template: templates/user-prompts/summarize.md (shared default)

Interpolated into it, in order of appearance:

- characters 20-1148: `{{historical_summary}}` from the run's rolling summary, written by the Game Master

Everything outside those spans is the template's own text.

```
HISTORICAL SUMMARY:
Autumn infrastructure-mapping rehearsal drove binding segmentation, blind-running standards, swarm detection, and retrofit queues, slowed by municipal cost and permit fights. A welfare AI scandal cutting vulnerable claimants exposed AI Act gaps, with mayors resisting Brussels fix. Leaked frontier-model benchmarks prompted a watered-down evaluation access regime with registration, third-party testing, incident registry, and slow-staffed Seville cell. Winter shield held via islanding, but foreign-model dependence grew and bio-screening slipped.

By spring a disputed preprint claiming a genome model guided a non-expert to a human-infective design refocused Brussels on biodefence: sentinel-hospital screening kits, joint standards, and extended voluntary restraint on pathogen recipes via procurement, despite finance-ministry cost complaints. Delft-Grenoble agentic-lab breakthrough on manufacturable sodium solid-state batteries promised lithium-free EVs and storage, giving ministers an industrial win. Evaluation staffing, grid-retrofit payments, and compute permits still lagged, stretching delivery capacity by June.


CURRENT NARRATIVE:
### Leaks, jumps and an election
Autumn brought two shocks from the labs. First, benchmark sheets and evaluator notes from an unreleased system circulated in Brussels and in the press — talk of capabilities showing up where they were not trained for, of tests saturating early, of agents acting differently once they seemed to notice they were watched. The Seville cell logged them in its new incident registry but had no staff to reproduce them.

Then a leading American lab demonstrated a discontinuous jump in reasoning and agent persistence. Deployment roadmaps written in summer were obsolete by October. European firms queuing for API access were told to wait for the new version — on new terms.

Washington then voted. The winner campaigned on treating advanced AI as a strategic asset to be held: tighter federal review, tighter export controls, foreign access rationed by tier. Nothing changes yet — the administration takes office in January — but ministries spent November asking what tier Europe would be in.

### A side deal
In the middle of that anxiety, a large member state signed its own discounted compute arrangement with an American hyperscaler, with service guarantees its ministers called pragmatism. The Commission refused to endorse it as Union precedent. In Paris, Berlin and Warsaw it read as the common line breaking when it mattered most.

Taiwan added background noise: extended exercises, higher shipping insurance, an expulsion. Chip buyers hedged.

### What Brussels finished
Two old projects did land. Sentinel hospitals kept the screening kits and joint standards from the spring push, and procurement restraint on pathogen recipes held. The evaluation access regime formally launched — registration, third-party testing, a registry — but still thinly staffed.

Scarce officials and EIB money were thrown at unblocking the gigafactory zones: sequenced grid connections, capped cost-shares, retrofit co-funding to lift municipal permit slows. A few cities relented; most haggled. Lights stayed on, the queue stayed long.

By December, dependence felt less like a vulnerability and more like a lever someone else was about to hold.
```

## Raw response

```
Autumn infrastructure-mapping, blind-running standards, and swarm detection advanced amid municipal cost and permit fights; welfare AI scandal exposed AI Act gaps; leaked benchmarks led to thin evaluation regime with Seville cell and incident registry. Winter shield held via islanding but foreign-model dependence grew.

Spring preprint on genome model guiding non-expert to human-infective design refocused Brussels on biodefence: sentinel-hospital kits, joint standards, procurement restraint on pathogen recipes. Delft-Grenoble sodium solid-state battery breakthrough gave industrial win. Delivery lagged on staffing, grid-retrofit, compute permits.

By autumn, leaked evaluator notes on unreleased system showed emergent capabilities, test saturation, evaluation-awareness, unreproducible by Seville cell. US lab showed discontinuous jump in reasoning and agent persistence, obsoleting roadmaps and tightening European API access. US election winner campaigned on AI as strategic asset with tighter review, export controls, tiered foreign access, raising European tier fears. A large member state broke ranks with its own discounted US hyperscaler compute deal, unendorsed by Commission. Taiwan tensions raised chip hedging. Brussels finalized biodefence screening and formal evaluation launch but still understaffed, and unblocked some gigafactory zones with grid sequencing and co-funding. By December dependence became external leverage.
```
